Combined Epidural Morphine and Midazolam on Postoperative Pain
Effect of Epidural Morphine and Midazolam on Postoperative Painin Patients Undergoing Major Abdominal Cancer Surgery
1 other identifier
interventional
20
1 country
1
Brief Summary
this study aim to Compare the effect of preoperative Epidural Midazolam, Morphine and their combination in postoperative pain relief and total morphine consumption.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_1
Started Jul 2019
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2019
CompletedFirst Submitted
Initial submission to the registry
July 24, 2019
CompletedFirst Posted
Study publicly available on registry
July 26, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2021
CompletedFebruary 24, 2021
February 1, 2021
1.7 years
July 24, 2019
February 23, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
time to first request of analgesia
the time between the end of operation and tracheal extubation to the first request for supplemental analgesics and its administration to the patient
1st 48 hours postoperative
Secondary Outcomes (1)
the cumulative consumption of morphine in the 1st 48h postoperatively
1st 48 hours postoperative
Study Arms (3)
MI
ACTIVE COMPARATORBupivacaine 0.25% + midazolam 5mg in total volume 10m1
MM
ACTIVE COMPARATORBupivacaine 0.25% + midazolam 5mg and morphine 5mg in total volume 10ml
MO
ACTIVE COMPARATORbupivacaine 0.25% + morphine 5 mg in total volume 10 ml
Interventions
epidural needle in the L1-2 or L2-3 space , and using loss of resistance technique udder strict aseptic condition 10 ml of the prepared drug will be given
Eligibility Criteria
You may qualify if:
- ASA I-II patients scheduled for major abdominal cancer surgeries
You may not qualify if:
- patients with known allergy to the study drugs,
- significant cardiac, respiratory, renal or hepatic disease,
- drug or alcohol abuse,
- psychiatric illness that would interfere with perception and assessment of pain.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Assiut University
Asyut, 171516, Egypt
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- associate professor of anesthesia, ICU and pain manegement
Study Record Dates
First Submitted
July 24, 2019
First Posted
July 26, 2019
Study Start
July 1, 2019
Primary Completion
March 1, 2021
Study Completion
April 1, 2021
Last Updated
February 24, 2021
Record last verified: 2021-02